$0.4091
-0.0032-0.78%
Last update: Nov 6, 8:39 AM
Caribou Biosciences Inc (CRBU) Stock Price, Quote, News & History
CRBUNASDAQ
Caribou Biosciences shares fall 35% after hours as the company weighs strategic alternatives and cuts two drug programs.
You can purchase shares of Caribou Biosciences (NASDAQ:CRBU) through any online brokerage.
Other companies in Caribou Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Caribou Biosciences has a consensus price target of $8.57.
The stock price for Caribou Biosciences (NASDAQ: CRBU) is $0.4091 last updated November 6, 2026 at 8:39 AM EST.
There are no upcoming dividends for Caribou Biosciences.
Caribou Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Caribou Biosciences.
Caribou Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The...
